08:19 AM EDT, 03/18/2025 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) said Tuesday that it has completed the buyout of its 3.125% perpetual royalty obligation to SWK Funding on global net revenue of Iluvien and Yutiq for a one-time payment of $17.3 million.

The company said it financed the buyout with cash on hand, and that no additional royalty is due to SWK on net revenue beginning Jan. 1 of this year and forward.

Shares of the company were down more than 1% in recent Tuesday premarket activity.